Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Ludwig Kappos(Novartis (Switzerland)), Ernst W. Radue(University Hospital of Basel), T Haas(Novartis (United States)), Jack P. Antel(Montreal Neurological Institute and Hospital), Paul O’Connor, Chris H. Polman(Vrije Universiteit Amsterdam), Giancarlo Comi(Vita-Salute San Raffaele University), Goeril Karlsson(Novartis (Switzerland)), Alexander Korn, Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya)
Cited by 1,054
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k